🇺🇸 FDA
Pipeline program

OMTX705-006 Phase 1b

OMTX705-006

Phase 1 other active

Quick answer

OMTX705-006 Phase 1b for Advanced/Metastatic Pancreatic Adenocarcinoma is a Phase 1 program (other) at Lacuna Pharma Pty Ltd with 1 ClinicalTrials.gov record(s).

Program details

Company
Lacuna Pharma Pty Ltd
Indication
Advanced/Metastatic Pancreatic Adenocarcinoma
Phase
Phase 1
Modality
other
Status
active

Clinical trials